Vivanza Biosciences consolidated net profit declines 92.31% in the September 2024 quarter

Net profit of Vivanza Biosciences declined 92.31% to Rs 0.02 crore in the quarter ended September 2024 as against Rs 0.26 crore during the previous quarter ended September 2023. Sales declined 60.63% to Rs 3.00 crore in the quarter ended September 2024 as against Rs 7.62 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	3.00	7.62	-61
OPM %	3.67	4.20	-
PBDT	0.02	0.26	-92
PBT	0.02	0.26	-92
NP	0.02	0.26	-92